非小细胞-话题@MedSci

#非小细胞#

746篇内容 | 6349人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2059630, encodeId=db3c2059630e4, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=SCI REP：外周血和肺静脉血循环肿瘤细胞预测非小细胞肺癌患者的长期生存率！, objectType=article, longId=105239, objectId=8abb10523993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8abb10523993, replyNumber=0, likeNumber=100, createdTime=2018-04-06, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8abb10523993, moduleTitle=SCI REP：外周血和肺静脉血循环肿瘤细胞预测非小细胞肺癌患者的长期生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8abb10523993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059644, encodeId=b6cc20596445e, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Eur Respir J：EGFR野生型进展性非小细胞肺癌：TKI vs化疗, objectType=article, longId=111675, objectId=74ad1116e521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ad1116e521, replyNumber=0, likeNumber=99, createdTime=2017-09-02, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ad1116e521, moduleTitle=Eur Respir J：EGFR野生型进展性非小细胞肺癌：TKI vs化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74ad1116e521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059669, encodeId=271e205966957, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=NCCN临床实践指南：非小细胞肺癌（2018.V1）, objectType=article, longId=121760, objectId=31d7121e606b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31d7121e606b, replyNumber=0, likeNumber=69, createdTime=2018-02-16, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31d7121e606b, moduleTitle=NCCN临床实践指南：非小细胞肺癌（2018.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31d7121e606b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059696, encodeId=ad2f2059696dd, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=MSD的keytruda在非小细胞肺癌的另一项临床试验中大获成功, objectType=article, longId=134813, objectId=9aa4134813ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aa4134813ac, replyNumber=0, likeNumber=81, createdTime=2018-10-17, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aa4134813ac, moduleTitle=MSD的keytruda在非小细胞肺癌的另一项临床试验中大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aa4134813ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059671, encodeId=b69920596e1f7, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=CFDA批准上市泰瑞沙®（甲磺酸奥希替尼片）审评概述，用于非小细胞性肺癌(NSCLC)成人患者的治疗, objectType=article, longId=122001, objectId=be1312200102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be1312200102, replyNumber=0, likeNumber=69, createdTime=2018-01-24, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be1312200102, moduleTitle=CFDA批准上市泰瑞沙®（甲磺酸奥希替尼片）审评概述，用于非小细胞性肺癌(NSCLC)成人患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be1312200102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059642, encodeId=49d0205964297, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=NEJM：ALK阳性非小细胞肺癌“头碰头”研究艾乐替尼更胜一筹, objectType=article, longId=111480, objectId=aacf11148072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aacf11148072, replyNumber=0, likeNumber=83, createdTime=2018-06-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aacf11148072, moduleTitle=NEJM：ALK阳性非小细胞肺癌“头碰头”研究艾乐替尼更胜一筹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aacf11148072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059665, encodeId=a89f2059665b9, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Lancet oncol：吉非替尼相比长春瑞滨联合顺铂治疗，可显著延长携带EGFR突变的晚期非小细胞肺癌术后患者的无病存活期。, objectType=article, longId=121145, objectId=f91412114508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f91412114508, replyNumber=0, likeNumber=83, createdTime=2017-12-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f91412114508, moduleTitle=Lancet oncol：吉非替尼相比长春瑞滨联合顺铂治疗，可显著延长携带EGFR突变的晚期非小细胞肺癌术后患者的无病存活期。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f91412114508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059613, encodeId=a334205961384, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=J CLIN ONCOL:放射治疗后的心脏事件：对局部晚期非小细胞肺癌的前瞻性多中心试验综合分析, objectType=article, longId=100990, objectId=c91b10099052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c91b10099052, replyNumber=0, likeNumber=103, createdTime=2017-11-01, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c91b10099052, moduleTitle=J CLIN ONCOL:放射治疗后的心脏事件：对局部晚期非小细胞肺癌的前瞻性多中心试验综合分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c91b10099052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059604, encodeId=4d2d2059604d0, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=CLIN CANCER RES：GRP78抗体增强胶质母细胞瘤及非小细胞肺癌放疗疗效, objectType=article, longId=99877, objectId=9c08998e776, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c08998e776, replyNumber=0, likeNumber=85, createdTime=2018-01-02, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c08998e776, moduleTitle=CLIN CANCER RES：GRP78抗体增强胶质母细胞瘤及非小细胞肺癌放疗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c08998e776)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059688, encodeId=2b7f20596883e, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=NCCN临床实践指南：非小细胞肺癌（2018.V3）, objectType=article, longId=130616, objectId=0bc21306166e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bc21306166e, replyNumber=0, likeNumber=65, createdTime=2018-11-13, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bc21306166e, moduleTitle=NCCN临床实践指南：非小细胞肺癌（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bc21306166e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059654, encodeId=70c420596545a, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Cancer Lett：新型自噬抑制剂千金藤碱能够增强非小细胞肺癌中dacomitinib的抗癌作用。, objectType=article, longId=116331, objectId=3f4e116331a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f4e116331a5, replyNumber=0, likeNumber=85, createdTime=2018-09-19, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f4e116331a5, moduleTitle=Cancer Lett：新型自噬抑制剂千金藤碱能够增强非小细胞肺癌中dacomitinib的抗癌作用。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f4e116331a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059610, encodeId=43a02059610fc, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=ASCO2017：克唑替尼用于ALK阳性非小细胞肺癌, objectType=article, longId=100784, objectId=52ba100e84d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52ba100e84d9, replyNumber=0, likeNumber=68, createdTime=2018-05-14, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52ba100e84d9, moduleTitle=ASCO2017：克唑替尼用于ALK阳性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ba100e84d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059611, encodeId=9480205961150, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=SCI REP：肺气肿是非小细胞肺癌患者肺癌放射治疗后发生放射性肺炎的危险因素！, objectType=article, longId=100844, objectId=dc7610084446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc7610084446, replyNumber=0, likeNumber=0, createdTime=2017-09-08, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc7610084446, moduleTitle=SCI REP：肺气肿是非小细胞肺癌患者肺癌放射治疗后发生放射性肺炎的危险因素！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc7610084446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059657, encodeId=a142205965e4b, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Lancet Oncol：Lorlatinib治疗ALK或ROS1重排的非小细胞肺癌, objectType=article, longId=117431, objectId=b55411e431ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b55411e431ee, replyNumber=0, likeNumber=72, createdTime=2017-10-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b55411e431ee, moduleTitle=Lancet Oncol：Lorlatinib治疗ALK或ROS1重排的非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b55411e431ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059591, encodeId=d9982059591a9, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=J Clin Oncol：年龄对非小细胞肺癌死亡率有何影响？, objectType=article, longId=95717, objectId=26c595e1706, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26c595e1706, replyNumber=0, likeNumber=91, createdTime=2017-06-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26c595e1706, moduleTitle=J Clin Oncol：年龄对非小细胞肺癌死亡率有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26c595e1706)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059648, encodeId=5c08205964820, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=CLIN CANCER RES：HGF/c-MET通路调节非小细胞肺癌VEGFR抑制剂耐药, objectType=article, longId=113909, objectId=a3b411390971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3b411390971, replyNumber=0, likeNumber=75, createdTime=2018-04-15, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3b411390971, moduleTitle=CLIN CANCER RES：HGF/c-MET通路调节非小细胞肺癌VEGFR抑制剂耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3b411390971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059624, encodeId=8d3920596244c, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=SCI REP：传统昆虫类中药联合化疗治疗非小细胞肝癌效果和安全性分析！, objectType=article, longId=103798, objectId=3321103e9839, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3321103e9839, replyNumber=0, likeNumber=62, createdTime=2018-01-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3321103e9839, moduleTitle=SCI REP：传统昆虫类中药联合化疗治疗非小细胞肝癌效果和安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3321103e9839)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059593, encodeId=84422059593cb, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Plos One：中国汉族人群的非小细胞肺癌易感性相关基因！, objectType=article, longId=96118, objectId=cd2f96118bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd2f96118bc, replyNumber=0, likeNumber=98, createdTime=2017-06-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd2f96118bc, moduleTitle=Plos One：中国汉族人群的非小细胞肺癌易感性相关基因！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd2f96118bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059592, encodeId=585b2059592dc, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Plos One：Cherlerythrine与厄洛替尼联合治疗对非小细胞肺癌的作用如何？, objectType=article, longId=95901, objectId=f73e9590141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f73e9590141, replyNumber=0, likeNumber=96, createdTime=2017-06-09, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f73e9590141, moduleTitle=Plos One：Cherlerythrine与厄洛替尼联合治疗对非小细胞肺癌的作用如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f73e9590141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059662, encodeId=df4e205966282, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Sci Rep：外源性miR-126作为非小细胞肺癌的生物标志物并调节癌症进展, objectType=article, longId=119775, objectId=c3af119e7500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3af119e7500, replyNumber=0, likeNumber=81, createdTime=2018-06-14, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3af119e7500, moduleTitle=Sci Rep：外源性miR-126作为非小细胞肺癌的生物标志物并调节癌症进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3af119e7500)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非小细胞

2020-05-29

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

SCI REP：外周血和肺静脉血循环肿瘤细胞预测非小细胞肺癌患者的长期生存率！

2018-04-06

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Eur Respir J：EGFR野生型进展性非小细胞肺癌：TKI vs化疗

2017-09-02

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

NCCN临床实践指南：非小细胞肺癌（2018.V1）

2018-02-16

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

MSD的keytruda在非小细胞肺癌的另一项临床试验中大获成功

2018-10-17

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

CFDA批准上市泰瑞沙®（甲磺酸奥希替尼片）审评概述，用于非小细胞性肺癌(NSCLC)成人患者的治疗

2018-01-24

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

NEJM：ALK阳性非小细胞肺癌“头碰头”研究艾乐替尼更胜一筹

2018-06-20

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Lancet oncol：吉非替尼相比长春瑞滨联合顺铂治疗，可显著延长携带EGFR突变的晚期非小细胞肺癌术后患者的无病存活期。

2017-12-29

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

J CLIN ONCOL:放射治疗后的心脏事件：对局部晚期非小细胞肺癌的前瞻性多中心试验综合分析

2017-11-01

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

CLIN CANCER RES：GRP78抗体增强胶质母细胞瘤及非小细胞肺癌放疗疗效

2018-01-02

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

NCCN临床实践指南：非小细胞肺癌（2018.V3）

2018-11-13

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Cancer Lett：新型自噬抑制剂千金藤碱能够增强非小细胞肺癌中dacomitinib的抗癌作用。

2018-09-19

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

ASCO2017：克唑替尼用于ALK阳性非小细胞肺癌

2018-05-14

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

SCI REP：肺气肿是非小细胞肺癌患者肺癌放射治疗后发生放射性肺炎的危险因素！

2017-09-08

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Lancet Oncol：Lorlatinib治疗ALK或ROS1重排的非小细胞肺癌

2017-10-26

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

J Clin Oncol：年龄对非小细胞肺癌死亡率有何影响？

2017-06-26

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

CLIN CANCER RES：HGF/c-MET通路调节非小细胞肺癌VEGFR抑制剂耐药

2018-04-15

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

SCI REP：传统昆虫类中药联合化疗治疗非小细胞肝癌效果和安全性分析！

2018-01-20

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Plos One：中国汉族人群的非小细胞肺癌易感性相关基因！

2017-06-04

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Plos One：Cherlerythrine与厄洛替尼联合治疗对非小细胞肺癌的作用如何？

2017-06-09

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Sci Rep：外源性miR-126作为非小细胞肺癌的生物标志物并调节癌症进展

2018-06-14

科室
- - 订阅+
  - 更多科室
工具
服务